Reuters logo
BRIEF-Akers Biosciences signs 3-year agreement with GNYHA for Heparin PF4 rapid test
December 19, 2016 / 12:18 PM / a year ago

BRIEF-Akers Biosciences signs 3-year agreement with GNYHA for Heparin PF4 rapid test

Dec 19 (Reuters) - Akers Biosciences Inc

* Akers Biosciences signs 3-year agreement with Greater new York Hospital Association for Heparin PF4 rapid test

* Akers Biosciences - under terms of agreement, co’s PIFA Heparin/PF4 Rapid Assay,PIFA PLUSS PF4 tests to be evaluated at 2 GNYHA member hospitals Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below